<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">23001</article-id><article-id pub-id-type="doi">10.7554/eLife.23001</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Total biosynthesis of the cyclic AMP booster forskolin from <italic>Coleus forskohlii</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-62786"><name><surname>Pateraki</surname><given-names>Irini</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7526-2334</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-74006"><name><surname>Andersen-Ranberg</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-74007"><name><surname>Jensen</surname><given-names>Niels Bjerg</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-74008"><name><surname>Wubshet</surname><given-names>Sileshi Gizachew</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74009"><name><surname>Heskes</surname><given-names>Allison Maree</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2732-5185</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74010"><name><surname>Forman</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74011"><name><surname>Hallström</surname><given-names>Björn</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74012"><name><surname>Hamberger</surname><given-names>Britta</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62397"><name><surname>Motawia</surname><given-names>Mohammed Saddik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62396"><name><surname>Olsen</surname><given-names>Carl Erik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74013"><name><surname>Staerk</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-74014"><name><surname>Hansen</surname><given-names>Jørgen</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-74015"><name><surname>Møller</surname><given-names>Birger Lindberg</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-67315"><name><surname>Hamberger</surname><given-names>Bjoern</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1249-1807</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf7"/></contrib><aff id="aff1"><institution content-type="dept">Plant Biochemistry Laboratory, Department of Plant and Environmental Sciences</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff2"><institution content-type="dept">Department of Plant and Microbial Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Evolva</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff4"><institution>Nofima</institution>, <addr-line><named-content content-type="city">Osloveien</named-content></addr-line>, <country>Norway</country></aff><aff id="aff5"><institution content-type="dept">Science for Life Laboratory</institution>, <institution>KTH - Royal Institute of Technology</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff6"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>Michigan State University</institution>, <addr-line><named-content content-type="city">East Lansing</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Drug Design and Pharmacology</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1048"><name><surname>Bohlmann</surname><given-names>Joerg</given-names></name><role>Reviewing editor</role><aff><institution>University of British Columbia</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>eipa@plen.ku.dk</email> (IP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>03</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e23001</elocation-id><history><date date-type="received"><day>05</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>09</day><month>03</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Pateraki et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Pateraki et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-23001-v1.pdf"/><abstract><p>Forskolin is a unique structurally complex labdane type diterpenoid used in the treatment of glaucoma and heart failure based on its activity as a cyclic AMP booster. Commercial production of forskolin relies exclusively on extraction from its only known natural source, the plant<italic> Coleus forskohlii</italic>, in which forskolin accumulates in the root cork. Here we report the discovery of five cytochrome P450s and two acetyltransferases which catalyze a cascade of reactions converting the forskolin precursor 13<italic>R</italic>-manoyl oxide into forskolin and a diverse array of additional labdane-type diterpenoids. A minimal set of three P450s in combination with a single acetyl transferase was identified that catalyzes the conversion of 13<italic>R</italic>-manoyl oxide into forskolin as demonstrated by transient expression in <italic>Nicotiana benthamiana</italic>. The entire pathway for forskolin production from glucose encompassing expression of nine genes was stably integrated into <italic>Saccharomyces cerevisiae </italic>and afforded forskolin titers of 40 mg/L.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008398</institution-id><institution>Villum Fonden</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Møller</surname><given-names>Birger Lindberg</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004191</institution-id><institution>Novo Nordisk</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Møller</surname><given-names>Birger Lindberg</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Pateraki</surname><given-names>Irini</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Irini Pateraki, Filed international patent600 applications (PCT/DK2015/050020) covering 'Biosynthesis of forskolin and related compounds.</p></fn><fn fn-type="conflict" id="conf3"><p>Johan Andersen-Ranberg, Filed international patent600 applications (PCT/DK2015/050020) covering 'Biosynthesis of forskolin and related compounds.</p></fn><fn fn-type="conflict" id="conf4"><p>Niels Bjerg Jensen, Filed international patent600 applications (PCT/DK2015/050020) covering 'Biosynthesis of forskolin and related compoundsEmployee of Evolva SA.</p></fn><fn fn-type="conflict" id="conf5"><p>Jørgen Hansen, Employee of Evolva SA.</p></fn><fn fn-type="conflict" id="conf6"><p>Birger Lindberg Møller, Filed international patent600 applications (PCT/DK2015/050020) covering 'Biosynthesis of forskolin and related compounds.</p></fn><fn fn-type="conflict" id="conf7"><p>Bjoern Hamberger, Filed international patent600 applications (PCT/DK2015/050020) covering 'Biosynthesis of forskolin and related compounds'.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-23001-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>